Cookie Policy

A full description of our cookie policy can be found here.

Essential (Required)

Cookies that the site cannot function without. This includes cookies for access to secure areas and CSRF protection. Please note that Craft's default cookies do not collect any personal or sensitive information. Craft's default cookies do not collect IP addresses. The information they store is not sent to Pixel & Tonic or any 3rd parties.

Name: CraftSessionId
Description: Craft relies on PHP sessions to maintain sessions across web requests. That is done via the PHP session cookie. Craft names that cookie “CraftSessionId” by default, but it can be renamed via the phpSessionName config setting. This cookie will expire as soon as the session expires.
Provider: biocatalysts.com
Expiry: Session

Name: *_identity
Description: When you log into the control panel, you’ll get an authentication cookie used to maintain your authenticated state. The cookie name is prefixed with a long, randomly generated string, followed by _identity. The cookie only stores information necessary to maintain a secure, authenticated session and will only exist for as long as the user is authenticated in Craft.
Provider: biocatalysts.com
Expiry: Persistent

Name: *_username
Description: If you check the "Keep me logged in" option during login, this cookie is used to remember the username for your next authentication.
Provider: biocatalysts.com
Expiry: Persistent

Name: CRAFT_CSRF_TOKEN
Description: Protects us and you as a user against Cross-Site Request Forgery attacks.
Provider: biocatalysts.com
Expiry: Session

BRAIN Biotech AG and Biocatalysts Ltd Launch a New Business Initiative to Revolutionise Enzyme Solutions within the Life Science Industry

Published 01 October 2024

Home/ Media & Resources/ BRAIN Biotech AG and Biocatalysts Ltd Launch a New Business Initiative to Revolutionise Enzyme Solutions within the Life Science Industry

BRAIN Biotech Zwingenberg and Biocatalysts Ltd have aligned their core competencies to revolutionise the enzyme development within the Life Science market by addressing the significant challenges with IP restrictions and scale up. The launch of BRAIN-Biocatalysts Life Science Solutions business combines BRAIN’s cutting-edge enzyme discovery and optimisation expertise with Biocatalysts’ world-class commercial-scale manufacturing, delivering an unparalleled, end-to-end solution for the life sciences sector. By offering end-to-end services, from enzyme discovery to large-scale manufacturing, this bold venture is set to disrupt the market by offering a transparent IP strategy that guarantees partners full control over their innovations.

The collaboration is powered by BRAIN Biotech AG’s unique enzyme discovery platform MetXtra™, combining bioinformatics, AI, and novel enzyme sequences. This comes alongside Biocatalysts’ state-of-the-art fermentation facility in Cardiff, UK housing fermentation capacities of up to 10,000L and comprehensive downstream processing capabilities. The collaboration is further enhanced by the proprietary “Plug & Produce” platform of microbial fermentation strains for immediate large-scale production, allowing partners to engage at any stage of development.

To spearhead this initiative, BRAIN-Biocatalysts Life Science Solutions has assembled a team of world-class experts, with decades of experience in enzyme solutions for molecular diagnostics and DNA modification alongside delivering biocatalytic solutions to the pharmaceutical industry for over 20 years.

Simplifying Enzyme Innovation

Your Product | Your IP | Your Future

“

With BRAIN-Biocatalysts Life Science Solutions we are the first in the market to offer a truly end-to-end enzyme development and production platform in the small molecule API, DNA modification and molecular diagnostics markets. This collaboration not only fills a critical gap, but also empowers partners with seamless enzyme development solutions from discovery to large-scale manufacturing, ensuring they can innovate without barriers

— Adriaan Moelker, CEO BRAIN Biotech AG